Nick Buglak joins the Bahnson Lab for the BBSP Spring Rotation to work on the therapeutic effect of cinnamic aldehyde, a nrf2 activator, to prevent arterial restenosis in diabetes. To learn more about Nick, visit his page.
Nick Buglak Joins the Bahnson Research Group for the Spring Rotation
Comments are closed.